Sectors
RGNX
REGENXBIO Inc.
10.23
1 x 10.18
5 x 10.21
bid
ask
-
0.19
1.82%
09:41 AM
timesize
| Ytd | -28.96% | |
| 1y | 37.13% |
10.19
day range
10.74
5.46
52 week range
16.19
| Open | 10.74 | Prev Close | 10.42 | Low | 10.19 | High | 10.74 | Mkt Cap | 528.43M |
| Vol | 72.47K | Avg Vol | 2.26M | EPS | -3.79 | P/E | -2.70 | Forward P/E | -6.83 |
| Beta | 0.94 | Short Ratio | 6.02 | Inst. Own | 92.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 9.95 | 200-d Avg | 10.52 | 1yr Est | 37.64 |
| Income Statement | |||
| Total Revenue | 108.02M | ||
| Revenues (USD) | 108.02M | ||
| Cost of Revenue | 1.04M | ||
| Gross Profit | 106.98M | ||
| Operating Expenses | 77.71M | ||
| Research and Development Expense | 56.09M | ||
| Selling, General and Administrative Expense | 21.62M | ||
| Operating Income | 29.26M | ||
| Interest Expense | 7.79M | ||
| Net Income | 22.71M | ||
| Net Income Common Stock | 22.71M | ||
| Net Income Common Stock (USD) | 22.71M | ||
| Consolidated Income | 22.71M | ||
| Earnings per Basic Share | 0.43 | ||
| Earnings per Basic Share (USD) | 0.43 | ||
| Earnings per Diluted Share | 0.43 | ||
| Earning Before Interest & Taxes (EBIT) | 30.50M | ||
| Earning Before Interest & Taxes (USD) | 30.50M | ||
| Weighted Average Shares | 52.82M | ||
| Weighted Average Shares Diluted | 53.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.52M | ||
| Cash and Equivalents (USD) | 38.52M | ||
| Investments | 69.03M | ||
| Investments Current | 69.03M | ||
| Trade and Non-Trade Receivables | 107.19M | ||
| Current Assets | 236.16M | ||
| Property, Plant & Equipment Net | 142.32M | ||
| Total Assets | 386.62M | ||
| Debt Current | 34.12M | ||
| Total Debt | 250.46M | ||
| Current Liabilities | 82.62M | ||
| Debt Non-Current | 216.34M | ||
| Total Liabilities | 314.85M | ||
| Accumulated Retained Earnings (Deficit) | -1.19B | ||
| Accumulated Other Comprehensive Income | -875.00K | ||
| Shareholders Equity | 71.77M | ||
| Shareholders Equity (USD) | 71.77M | ||
| Assets Non-Current | 150.46M | ||
| Total Debt (USD) | 250.46M | ||
| Deferred Revenue | 25.29M | ||
| Liabilities Non-Current | 232.23M | ||
| Trade and Non-Trade Payables | 15.55M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.76M | ||
| Net Cash Flow from Financing | 17.57M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 21.26M | ||
| Capital Expenditure | -760.00K | ||
| Issuance (Purchase) of Equity Shares | 19.38M | ||
| Issuance (Repayment) of Debt Securities | -1.81M | ||
| Net Cash Flow from Investing | 65.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 66.69M | ||
| Net Cash Flow from Operations | -62.24M | ||
| Share Based Compensation | 9.05M | ||